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Abstract. 24 
The phosphoinositide 3-kinase (PI 3-kinase)/Akt signaling pathway plays essential roles 25 
during neuronal development. The 3-phosphoinositide-dependent protein kinase 1 (PDK1) 26 
coordinates the PI 3-kinase signals by activating twenty three kinases of the AGC family 27 
including Akt. Phosphorylation of a conserved docking site in the substrate is a requisite for 28 
PDK1 to recognize, phosphorylate and activate most of these kinases, with the exception of 29 
Akt. We exploited this differential mechanism of regulation by generating neuronal-specific 30 
conditional knock-in mice expressing the mutant form of PDK1 L155E in which the 31 
substrate-docking site binding motif, termed the PIF-pocket, was disrupted. As a 32 
consequence, activation of all the PDK1 substrates tested excluding Akt was abolished. 33 
Mice exhibited microcephaly, altered cortical layering and reduced circuitry, leading to 34 
cognitive deficits and exacerbated disruptive behavior combined with diminished 35 
motivation. The abnormal patterning of the adult brain arise from the reduced ability of the 36 
embryonic neurons to polarize and extend their axons, therefore highlighting the essential 37 
roles that the PDK1 signaling beyond Akt plays in mediating the neuronal responses that 38 
are instructive for brain development. 39 
40 
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 Introduction. 41 
The phosphoinositide 3-kinase (PI 3-kinase) signaling pathway regulates cell survival, 42 
proliferation, growth, motility as well as metabolism in response to extracellular signals. 43 
Class I PI 3-kinases phosphorylate the membrane phospholipid phosphatidylinositol-4,5-44 
bisphosphate (PtdIns(4,5)P2) to generate the phosphatidylinositol-3,4,5-trisphosphate 45 
(PtdIns(3,4,5)P3) second messenger (1,2). In neurons, stimulation of PI 3-kinase by 46 
neurotrophic factors, neurotransmitters or guidance cues results in the activation of the 47 
Protein Kinase B (PKB, also termed Akt), the most studied downstream effector of this 48 
signaling pathway. Akt phosphorylates and inactivates a number of cellular substrates 49 
controlling different aspects of neuronal development. These include PRAS40 and TSC2, 50 
leading to mTORC1 activation, which in turns promotes the synthesis of selected sets of 51 
proteins involved in the differentiation program (3); GSK3, which regulate cytoskeleton 52 
dynamics and participate in the establishment and maintenance of neuronal polarity (4,5); 53 
and FOXO, that promote the expression of genes inhibiting apoptosis (6). Genetic analysis 54 
in mice has uncovered the functional significance of PI 3-kinase for brain morphology and 55 
physiology (7-10), whereas deregulation of this signaling pathway has pathophysiological 56 
consequences in human neurodevelopmental disorders such as schizophrenia (11-13) and 57 
autism (14,15). 58 
The 3-phosphoinositide-dependent protein kinase-1 transduces many agonist-induced 59 
cellular responses by activating an entire set of AGC kinase-family members in addition to 60 
Akt (16). These include S6K, SGK, RSK and PKC isoforms. Upon cell stimulation, PDK1 61 
is enabled to phosphorylate the T-loop of all these AGC kinases, resulting in their 62 
activation (17,18). 63 
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Since PDK1 is constitutively active in cells, the previous phosphorylation of a second 64 
activating residue located in a C-terminal conserved hydrophobic motif becomes rate 65 
limiting for PDK1 to bind and activate most substrates. The phosphorylated hydrophobic 66 
motif acts in this manner as a substrate-docking site recognized by a small groove within 67 
the PDK1 catalytic domain termed PIF-pocket (19,20). By contrast, phosphorylation of Akt 68 
at the hydrophobic motif is not required for PDK1 to activate this kinase. The exclusive 69 
presence in both PDK1 and Akt of pleckstrin homology (PH) domains able to specifically 70 
interact with PtdIns(3,4,5)P3 results in their co-localization at the plasma membrane, where 71 
PDK1 can phosphorylate and activate Akt (16). 72 
The final demonstration that these two mechanisms operates in vivo came from the analysis 73 
of two single-aminoacid, rationally designed PDK1 mutations abrogating the function of 74 
either the PH-domain or the PIF-pocket motif (21). We recently reported how in the 75 
PDK1K465E/K465E knock-in mice, which express a mutant form of PDK1 incapable of 76 
phosphoinositide binding, activation of Akt was selectively affected. As a consequence, the 77 
ability of hippocampal and cortical embryonic neurons to differentiate was markedly 78 
impaired (22). 79 
Full knock-in mice expressing a mutant form of PDK1 in which the Leucine residue at 80 
position 155 within the PIF-pocket was replaced by Glutamic acid (L155E) were previously 81 
generated, which died at mid gestation. In the PDK1L155E/L155E mice, activation of all the 82 
PDK1-regulated substrates with the exception of Akt was totally abolished (23). To define 83 
the contribution of the PDK1 signaling beyond Akt to neurodevelopmental regulation, here 84 
we targeted the expression of the PDK1 L155E mutant protein to the developing brain. The 85 
PDK1 mutant mice were microcephalic, with neuronal polarization and axonal elongation 86 
significantly inhibited in the mutant neurons. As a consequence, the patterning of the brain 87 
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was dramatically perturbed, as denoted by cortical layering alterations and reduced circuitry. 88 
These resulted in impaired cognition along with abnormal behaviors, which further 89 
highlights the importance of PDK1 targets different from Akt in mediating signaling 90 
responses that are key to brain development. 91 
92 
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Materials and methods 93 
Mice 94 
The Nestin-Cre transgenic mice were kindly provided by Professor Ulrich Mueller at the 95 
Scripps Research Institute (24), whereas the PDK1 L155E conditional knock-in mice and 96 
the genotyping procedures were previously described (25). Animal maintenance conditions 97 
and experimental research was performed in accordance with 2010/63/UE regarding the 98 
care and use of animals for experimental procedures. The study complies with the ARRIVE 99 
guidelines developed by the NC3Rs (26). 100 
Primary cultures 101 
Neuronal primary cultures were established from E15,5 embryos as previously described 102 
(22). Cortical cells were plated at a density of 20x104 cells/ml on 50 µg/ml of poly-D-103 
Lysine- coated plates and maintained for six days in vitro (DIV) before treatments, whereas 104 
hippocampal cells were plated at a density of 7.5x104 cells/ml onto 12-mm glass coverslips 105 
coated with 150 µg/ml poly-D-Lysine placed in 24-well plates for four days in vitro. 106 
MRI analysis 107 
Adult mice were terminated, brains dissected and right hemispheres kept at - 80ºC for 108 
biochemical analysis. Left hemispheres were fixed for 2 hours in 4% paraformaldehyde, 109 
preserved in 70% ethanol solution at 4ºC and embedded in 1,5% agarose in PBS. 1H-110 
Magnetic resonance imaging studies were performed in a 7T Bruker BioSpec 70/30 USR 111 
spectrometer equipped with a mini-imaging gradient set (400mT/m), a 72 mm inner 112 
diameter circular polarized linear transmitter volume coil and a received-only mouse head 113 
surface coil. Images were acquired using a multislice fast low angle shot (FLASH) 114 
sequence from the Bruker Paravision® 5.1 library (repetition time = 450ms, echo time = 115 
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5.4ms, excitation flip angle = 40º) in 33 contiguous slices with 0.5 mm thickness, an 116 
acquisition matrix of 256×256, and a field of view 19.2mm×19.2mm, giving a voxel 117 
resolution of 0.0028125mm3. Imaging data were Fourier transformed in ParaVision, and 118 
then visualized using the ImageJ software. 119 
Determination of organ volume and cell size 120 
Organ volume was determined using the Cavalieri method (27) applied to either MRI 121 
datasheets of the adult brain or physical sections of embryonic brain samples. MRI images 122 
were displayed on ImageJ, outlined and the total number of pixels multiplied by the voxel 123 
resolution and by a factor of 2 to obtain the adult brain volume, which was assumed as 124 
twice the volume of one hemisphere. Embryonic brain paraffin sections of 5 μm were 125 
collected at systematically spaced locations (k=96 µm) from a random starting position and 126 
photographed with a Nikon SMZ800 stereomicroscope at 1X magnification using a digital 127 
camera. A square lattice grid of 0.9149 mm2 (d2) was then overlaid on the picture using the 128 
program Photoshop version vCS5.1 and the number of intersections (P) hitting either the 129 
whole head or the brain scored. The volume was estimated by using the equation P x d2 x 130 
k. The number and size of the cells was determined on E15.5 dissociated cortex tissues with 131 
the ScepterTM 2.0 Handheld Automated Cell Counter (Millipore). 132 
Evaluation of neuronal proliferation, apoptosis and survival 133 
For the survival studies, cortical neurons obtained at E15,5 were cultured in complete 134 
Neurobasal media supplemented with B27 for six days in vitro, washed twice with DMEM 135 
without serum and then either re-incubated in conditioned media or trophic deprived for 24 136 
hours in serum-free Neurobasal medium in the absence or presence of 50 ng/ml of BDNF 137 
(Brain derived neurotrophic factor; Alomone). Cell viability was determined by the MTT 138 
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(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reduction assay, whereas 139 
the percentage of apoptosis was determined upon Hoechst staining by scoring the number 140 
of cells with fragmented or condensed nuclei, as described (22). For the proliferation and 141 
apoptosis studies, E15,5 cortical neurons were cultured in complete Neurobasal media 142 
supplemented with B27 for the indicated days in vitro and then processed for 143 
immunocytochemistry with antibodies recognizing the Ki67 proliferation marker and the 144 
active caspase-3 apoptotic marker. 145 
Immunocytochemistry 146 
Cells were fixed in 4% paraformaldehyde in PBS for 20 min at room temperature, rinsed 147 
twice with PBS, permeabilized with 0.02% saponin diluted in PBS for 7 min at room 148 
temperature and blocked with 5% BSA, 0.01% saponin, 10 mM glycine in PBS for 1 h at 149 
room temperature. Primary antibodies diluted in PBS with 0.01% saponin and 1% normal 150 
goat serum were incubated overnight at 4ºC. Cells were then incubated with the appropriate 151 
secondary antibodies diluted 1:400 in the same solution for 90 min and counterstained with 152 
1µg/ml of Hoechst 33342 for 30 min. Coverslips were mounted onto microscope slides 153 
with FluorSave Reagent. 154 
Evaluation of differentiation 155 
Hippocampal cells fixed at different days in vitro were immunostained with the dendritic 156 
marker MAP2, the axonal marker Tau1 and counterstained with 1 µg/ml of the nuclear dye 157 
Hoechst 33342. Images for the green, red and blue channels were taken simultaneously 158 
with an epifluorescence microscope (Nikon Eclipse 90i) interfaced to a DXM 1200F 159 
camera at a 20X magnification. The number and length of axons, dendrites, dendritic 160 
branches and the soma diameter were measured with the NeuronJ plugin and scored with 161 
the Cell counter from ImageJ 1.42q (Wayne Rasband, National Institutes of Health). 162 
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Generation of protein extracts and western blot analysis 163 
E15,5 cortical neurons cultured for six days in vitro in complete Neurobasal media 164 
supplemented with B27 were starved for 4 h in Neurobasal without B27 and subsequently 165 
stimulated with 50 ng/ml BDNF for 15 minutes. Cells were scrapped from wells in ice-cold 166 
Lysis Buffer (50 mM Tris-HCl pH 7.5, 1 mM EGTA, 1 mM EDTA, 1 mM sodium 167 
orthovanadate, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 10 mM sodium-168 
glycerophosphate, 0.27 M sucrose, 1% w/v Triton X-100, 0.1% v/v 2-mercaptoethanol, and 169 
a 1:100 dilution of protease inhibitor cocktail, Sigma). Tissue extracts were prepared by 170 
homogenizing on ice the frozen tissue in a 10-fold volume excess of ice-cold Lysis Buffer 171 
using the Polytron. Lysates were centrifuged at 4°C for 10 min at 13.000 rpm and 172 
supernatants aliquoted and preserved at -20°C. Protein concentrations were determined by 173 
the Bradford method using bovine serum albumin as a standard. The activation state of the 174 
different pathways was assessed by immunoblotting the extracts (10 µg) with the indicated 175 
antibodies, which were detected with the appropriate horseradish peroxidase-conjugated 176 
secondary antibodies. Membranes were incubated with the enhanced chemiluminescence 177 
reagent (ECL), then either exposed to Super RX Fujifilm and developed, or detected using 178 
a ChemiDoc MP Imaging System (Biorad), and then quantified by using the ImageJ 179 
software. 180 
Affinity purification of PDK1. 181 
10 µl of Streptavidin-Sepharose (GE Heathcare) was conjugated to 0.5 µg of biotinylated 182 
PIF peptide (Biotin-C6 spacer-REPRILSEEEQEMFRDFAYIADWC) and incubated with 183 
0.3 mg of pre-cleared tissue lysates at 4 ºC overnight on a shaking platform. The pull-184 
downs were washed twice with 1 ml of Lysis Buffer supplemented with 150 mM NaCl, 185 
resuspended in Sample Loading Buffer, electrophoresed and then immunoblotted for PDK1. 186 
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Antibodies.  187 
The Akt and PRAS40 total antibodies were kindly provided by Dario Alessi from the 188 
University of Dundee. The PDK1 (#3062), TrkB Tyr706/707-P (#4621), TrkB (#4603), Akt 189 
Thr308-P (#4056), Akt Ser473-P (#4060), PRAS40 Thr246-P (#2997), pan-PDK1 site 190 
PKCγ Thr514-P antibody (#9379), S6K Thr389-P (#9234), S6K (#9202), S6 protein 191 
Ser235/236-P (#4858), S6 protein (#2217), ERK1/2 (#9102), RSK Ser380-P (#9335) and 192 
RSK 1/2/3 (#9355) antibodies were purchased from Cell Signaling Technology. The RSK 193 
Ser227-P (#12445) antibody was obtained from Santa Cruz Biotechnology, the SGK1 194 
antibody (#S5188) from Sigma, and the PKCα antibody (#P16520) from Transduction 195 
Laboratories. Secondary antibodies were from Pierce. 196 
For immunofluorescence experiments we used the Tau-1 (#MAB3420), the GAD67 197 
(#MAB5406), the Parvoalbumin (#MAB1572) and the NeuN (#MAB377) antibodies from 198 
Millipore, the pan-axonal neurofilament (#SMI-312R) antibody from Covance, the rabbit 199 
MAP2 (#M3696) antibody from Sigma, the CUX1 (#13024) antibody from Santa Cruz 200 
Biotechnology, the Ki67 (#ab156956) and the Doublecortin (#ab18723) antibodies from 201 
Abcam, and the Caspase-3 cleaved (#9661) antibody from Cell Signaling. Alexa Fluor 594-202 
conjugated goat anti-rabbit (#A11072), Alexa Fluor 488-conjugated goat anti-mouse 203 
(#A11017) and Alexa Fluor 594-conjugated goat anti-rat (#A11007) secondary antibodies 204 
were obtained from Molecular Probes (Life Technologies). 205 
Immunohistochemistry 206 
Adult mice were intraperitoneally anesthetized with 0.4 mg/g body weight of pentobarbital, 207 
then an intracardiac injection of 70 heparin units was administered before perfusion with 208 
0.9% NaCl followed by 4% buffered paraformaldehyde. Brains were extracted, post-fixed 209 
for 2 hours in 4% paraformaldehyde and preserved in 70% ethanol solution at 4ºC. 210 
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Embryos were dissected from E15,5 plug-tested pregnant females, decapitated, the whole 211 
head fixed for 2 hours in 4% paraformaldehyde and then preserved in 70% ethanol solution 212 
at 4ºC. In both cases, samples from three littermates of different genotype were embedded 213 
in the same paraffin block, with a final number of blocks of three, which were then sliced 214 
into 5µm thick coronal sections with a Leica RM2255 microtome. Sections were dry-heated 215 
for 2 hours at 60ºC, rehydrated, boiled 10 min in 10 mM sodium citrate pH 6 for antigen 216 
retrieval, cooled down for 30 min on ice and washed three times with Tris-buffered saline 217 
(TBS; 25 mM Tris pH7.5, 150 mM NaCl). Samples were blocked in TBS containing 0.02% 218 
Triton and 5% goat serum for 30 min and incubated overnight at 4°C with primary 219 
antibodies diluted in the same blocking solution. Sections were rinsed with TBS buffer, 220 
incubated for 1,5 hours at room temperature with the corresponding secondary antibodies 221 
diluted 1:400 in TBS and counterstained with 1 μg/ml Hoechst 33342 before mounting in 222 
Fluorsave reagent. Immunostained sections were photographed with a Nikon Eclipse 90i 223 
epifluorescence microscope, and the captured images were processed and analyzed with 224 
ImageJ 1.42q (Wayne Rasband, National Institutes of Health) and Fiji (http://pacific.mpi-225 
cbg.de/wiki/index.php/Main_Page) software. 226 
Behavioral Analysis 227 
A sample of six PDK1fl/fl CRE+ mutant and six PDK1fl/fl CRE- matched controls twelve-228 
months old female mice were confronted to a standardized battery of behavioral tests 229 
(28,29) administered during 10 consecutive days, as a preliminary screening of the 230 
behavioral phenotypes of the mutant mice. On day 1, observation of undisturbed behavior 231 
in the homecage including sociability, barbering and sleeping in groups pattern, was 232 
immediately followed by the assessment of several sensorimotor tasks. Motor coordination 233 
and equilibrium were assessed in the wood and rod tests, by the distance covered and the 234 
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latency to fall off a horizontal 1.3 cm-wide wooden rod and a 1 cm-diameter wire rod on 235 
two consecutive 20 s trials. Prehensility and motor coordination were measured as the 236 
distance covered on the wire hang test, where the animals were allowed to cling with its 237 
forepaws for two trials of 5 s and a third 60 s trial. Muscle strength was measured as the 238 
time until falling off the wire in the 60 s trial. Nesting behavior using paper towel was 239 
measured in isolation (housing condition on day 10), according to Deacon’s 5-point scale 240 
(30). The secondary and tertiary screen address neuropsychiatric-like deficits by assessing 241 
spontaneous exploratory behavior, anxiety-like behaviors, circadian activity and cognition 242 
in a series of test involving different degrees of complexity. Neophobia in the corner test 243 
was recorded on day 2, in a new home-cage by the horizontal (n of visited corners) and 244 
vertical (n and latency of rearings) activity during a period of 30s. Immediately after, 245 
exploratory activity and anxiety-like behaviors in a standard open-field test were measured 246 
for 10 min. Horizontal (cm) and vertical (rearings) locomotor activities were recorded for 247 
each minute of the test. The following items of behavior were recorded: Freezing (latency 248 
of initial movement), thigmotaxis (latency of leaving the central square and that of entering 249 
in the peripheral ring 10 cm to the walls), and self-grooming behavior (latency, number and 250 
duration of groomings). Defecation and urination were also measured. On day 3, marble-251 
burying test was performed in standard cages containing 10 glass marbles (1x1x1 cm) 252 
evenly spaced on a 5 cm thick layer of sawdust.  Latency to contact a piece of marble was 253 
measured and at the end of the 30-min test, the number of marbles was counted as follows: 254 
Intact (number of marbles unmanipulated), Change position (the number of marbles at least 255 
½ buried by sawdust and change rotated 90º or 180º) and Buried (the number of marbles 256 
100% buried by sawdust) (30). On the next three days (days 4-6), the perceptual visual 257 
learning and spatial learning and memory were assessed in a 3-days water maze. Animals 258 
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were trained to criterion (90% escaping in under 60 s) in a series of cued visible platform 259 
trials (7 cm diameter, 1 cm above the water surface, position indicated by a visible 5 x 8 cm 260 
striped flag, 20 min inter-trial time) in a pool (Intex Recreation Corp. CA, USA; 91 cm 261 
diameter, 40 cm deep, 25ºC opaque water). This required four platform trials (CUE1–262 
CUE4). The last visible platform trial of any animal is considered to be its post-habituation 263 
baseline, and is designated CUE4 (cued visible platform trial 4). Mice that failed to find the 264 
platform within 60 s were manually guided to the platform and placed on it for 5–10 s, the 265 
same period as successful animals. 24 h after the last cued platform trial, the animals were 266 
tested in a series of four hidden platform trials (PT1–PT4, 20 min apart). In these place-267 
learning task, the hidden platform (1.5 cm below the water surface) was located in a new 268 
position, reversal to the one used for cue-learning. Escape latencies were measured with a 269 
stop-watch. Episodes of immobility (flotation) were measured. On days 7-10, circadian 270 
motor activity was tested for 84 consecutive hours in a home cage equipped with a running 271 
wheel (31).  272 
Statistical analysis 273 
Two-way analysis of variance and Student’s t test analysis were applied to compare 274 
differences among categories, where * indicates P < 0.05 and ** P < 0.005 compared to 275 
controls as depicted in the figures. Data analysis was done using the GraphPad Prism 276 
software (GraphPad Software, La Jolla, CA, USA). 277 
278 
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Results 279 
Generation of neuronal-specific PDK1 L155E knock-in mice. 280 
We followed the minigene conditional knock-in approach to limit the expression of the 281 
PDK1 mutant protein to the neuronal lineage (25). In this method, a conditional allele was 282 
constructed in which the wild type protein is expressed from the endogenous locus through 283 
the first two PDK1 exons, whereas expression of the remaining coding region occurs 284 
through a LoxP site-flanked minigene DNA cassette consisting on the wild type PDK1 285 
open reading frame from exons 3 to 14 followed by the natural transcriptional termination 286 
and polyadenylation signals. The construct is designed so that upon CRE-Recombinase 287 
mediated excision of the floxed minigene, a mutated version of exon 4 coding for glutamic 288 
acid at position 155 of the mouse PDK1 protein will be transcribed (Fig. 1A). 289 
A potential drawback of this floxed allele is its reported inability to efficiently use the 290 
termination signals of the minigene cassette to finish transcription, which continued into the 291 
knock-in region of the gene even in the absence of CRE and produced significant amounts 292 
of mRNA for mutant PDK1 (25). However, we reasoned that this attribute, upon the 293 
appropriate genetic crosses, would give rise to a valuable allelic series with increasing 294 
expression of the mutant PDK1 protein. Hence, mice homozygous for the PDK1 295 
conditional transgen were crossed with Nestin-CRE mice, which express the CRE-296 
Recombinase under the control of the neuron-specific enhancer of the nestin promoter in 297 
precursors of both neurons and glia starting at embryonic day E10.5 (24). The PDK1 298 
L155E conditional floxed allele will be referred as PDK1fl through the text for simplicity. 299 
The PDK1fl/fl CRE+ mice, but not the PDK1+/fl CRE-, PDK1+/fl CRE+ or PDK1fl/fl CRE- 300 
mice, were born at a reduced Mendelian distribution (Fig. 1B). We confirmed that the 301 
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PDK1 protein was expressed at similar levels in samples of the different genotypes 302 
analyzed (Fig. 1C). We next incubated protein extracts from either brain or liver with 303 
Sepharose conjugated to PIF-tide, a synthetic polypeptide corresponding to the aminoacid 304 
sequence of the PDK1 substrate-docking site. The PIF-tide interacts strongly with the PIF-305 
pocket of wild type PDK1 but cannot interact with the PDK1 L155E mutant protein (32,33). 306 
PDK1 could be affinity-purified with high efficiency from PDK1+/fl CRE-, PDK1+/fl CRE+ 307 
and, to a lesser extent, from PDK1fl/fl CRE- brain extracts, but not from the PDK1fl/fl CRE+ 308 
mutant mice brain extracts, thereby biochemically confirming the expected gradation in the 309 
expression of the mutant PDK1 L155E protein rather than the wild type one. As a control, 310 
we demonstrated that in the liver tissues, which does not express CRE, PDK1 could be 311 
affinity-purified with the same reduced efficiency from the PDK1fl/fl CRE- and PDK1fl/fl 312 
CRE+ mice, that are homozygous for the conditional, leaky allele, in comparison to the 313 
PDK1+/fl CRE- and PDK1+/fl CRE+ controls, which retain a wild type copy of the PDK1 314 
gene (Fig. 1C). 315 
The resultant PDK1fl/fl CRE+ mutant mice as well as the PDK1fl/fl CRE- control mice, which 316 
also express high levels of the PDK1 L155E mutant protein in non-neuronal tissues (Fig. 317 
1C), were viable, fertile, and displayed a 25% reduction in body weight compared to 318 
PDK1+/fl CRE- mice, which retain a wild type copy for the PDK1 gene (Fig. 2B). 319 
Stereological analysis demonstrated that both the brain and the head volumes were 320 
proportionally reduced by 20% in the PDK1fl/fl CRE- and PDK1fl/fl CRE+ E15,5 embryos 321 
when compared to the PDK1+/fl CRE- controls (Fig. 2A, C). While the PDK1fl/fl CRE- mice 322 
exhibited a 25% reduction in both the volume and the mass of the brain when compared to 323 
the PDK1+/fl CRE- controls which is proportional to the reduction in the body weight, the 324 
PDK1fl/fl CRE+ adult mutant mice exhibited microcephaly, with brains showing a reduction 325 
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of about 50% in volume and mass than those from the PDK1+/fl CRE- controls (Fig 2D). 326 
Determination of the volume of the neuronal soma and the number of neuronal cells 327 
purified at E15,5 from the embryonic cortex suggested that the small brain size of the 328 
PDK1fl/fl CRE- and PDK1fl/fl CRE+ mice might be mostly due to a reduction in the size of 329 
the cells rather than to reduced number of cells (Fig. 2E, F). 330 
 S6K, RSK, SGK and PKC are not activated in the PDK1fl/fl CRE+ brain. 331 
To define the importance of the PDK1 substrate-docking site in the ability of PDK1 to 332 
activate its different cellular targets, primary cultures of cortical neurons derived from 333 
littermate PDK1+/fl CRE-, PDK1fl/fl CRE- and PDK1fl/fl CRE+ embryos were stimulated with 334 
BDNF for 15 minutes. As a control of the stimulation, the activation of the BDNF receptor 335 
TrkB was monitored by measuring its phosphorylation at the activation loop residues 336 
Tyr706/707, which was very robust in all the three genotypes analyzed (Fig 3A). By 337 
contrast, phosphorylation of TrkB was not detectable in whole brain tissue lysates at E15,5, 338 
despite the high levels of expression of the receptor (Fig 3B). 339 
BDNF induced a clear activation of Akt to the same extent in all the three genotypes 340 
analyzed, as judged by the level of phosphorylation of the two activating residues, Thr308 341 
and Ser473. This was corroborated by measuring the phosphorylation levels of the Akt 342 
substrate PRAS40 at Thr246, which was not affected by the PDK1 L155E mutation (Fig 343 
3A). To further validate this data in a more physiological context, the levels of 344 
phosphorylation and activation of Akt were also measured in whole protein extracts derived 345 
from the E15,5 developing brain, which were similar in all the three different genotypes 346 
analyzed (Fig. 3B).  347 
By contrast, phosphorylation of S6K at the T-loop Thr229 site by PDK1 was markedly 348 
reduced in the PDK1fl/fl CRE- cell and tissue samples when compared with the PDK1+/fl 349 
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CRE- controls, and almost abolished in the PDK1fl/fl CRE+ samples. As a consequence, S6K 350 
activation, as monitored by the phosphorylation of the S6 ribosomal protein at Ser235, was 351 
similarly affected (Fig. 3). 352 
BDNF also induced a robust autophosphorylation of the Ser380 hydrophobic motif site of 353 
RSK and the consequent recognition and phosphorylation of the Ser227 T-loop site by 354 
PDK1 (34) in the PDK1+/fl CRE- control cells. By contrast, phosphorylation of RSK at 355 
Ser227 by PDK1 was gradually reduced in the PDK1fl/fl CRE- and PDK1fl/fl CRE+ cells and 356 
tissues (Fig. 3). 357 
Activation of SGK1 requires the phosphorylation of the hydrophobic motif at Ser422 by 358 
mTORC2, which primes the binding of PDK1 (35). As expected, BDNF-induced 359 
phosphorylation of SGK1 at the Thr256 PDK1 site within the T-loop was reduced in the 360 
PDK1fl/fl CRE- cortical cultures when compared with the PDK1+/fl CRE- controls, and 361 
further decreased in the PDK1fl/fl CRE+ samples and tissues (Fig. 3). 362 
PDK1 also controls the stability of PKC isoforms through the phosphorylation of their T-363 
loop sites (36). We found both the levels of phosphorylation as well as the levels of 364 
expression of PKCα reduced in the PDK1fl/fl CRE+ cells and tissues (Fig. 3) compared to 365 
the PDK1fl/fl CRE- and PDK1+/fl CRE- samples. 366 
Binding of the PDK1 PIF-pocket to the substrate docking site is not essential to 367 
support neuronal survival. 368 
The neuronal-specific PDK1 PIF-pocket mutation most likely compromised growth 369 
responses during brain development, leading to microcephaly in the PDK1fl/fl CRE+ mutant 370 
adult mice. It is well known than the PI3K/PDK1/Akt signaling pathway plays critical roles 371 
in mediating the responses to survival signals that antagonize the intrinsic programmed cell 372 
death in the developing nervous system (6,37). We recently showed how decreasing the 373 
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efficiency of PKB/Akt activation by expressing the mutant form of PDK1 K465E incapable 374 
of phosphoinositide binding had no consequences on neuronal survival (22). From that it 375 
was postulated that either the reduced levels of Akt activity attained in the PDK1K465E/K465E 376 
mice were sufficient to preserve normal neuronal viability, or that other PDK1-activated 377 
kinases different from Akt were responsible for transducing the survival program elicited 378 
by extracellular signals. To address this question, we took advantage of the PDK1 L155E 379 
neuronal-specific knock-in mice. Neuronal programmed cell death can be accurately 380 
recapitulated in vitro in primary cultures of embryonic cortical neurons, which survive in 381 
the presence of particular neurotrophins such as BDNF and die through apoptosis upon 382 
trophic factor withdrawal. Trophic factor deprivation induced the death of  about half of the 383 
cells, as denoted by a fifty per cent decrease in the MTT reduction values (Fig 4A) and a 384 
five-fold increase in the number of apoptotic cells (Fig 4B-C) in all the four genotypes 385 
analyzed. BDNF completely recovered the cell viability values (Fig 4A) while decreasing 386 
by two to three-folds the number of cells exhibiting apoptosis (Fig 4B-C) to the same extent 387 
in all the four genotypes analyzed. From this it was concluded that the PDK1 PIF-pocket 388 
dependent AGC kinases were neither essential for the neuroprotective actions of BDNF, at 389 
least in cortical neurons. 390 
We next measured proliferation as well as cell death parameters on primary cultures of 391 
cortical neurons during the first four days in vitro by using the Ki67 proliferation marker 392 
and the cleaved/active caspase-3 apoptotic marker. At day in vitro 0 (DIV0), the PDK1+/fl 393 
CRE- control cultures reached highest proliferation rates above 20%, which were 394 
significantly reduced in both the PDK1fl/fl CRE- and PDK1fl/fl CRE+ cultured cortical 395 
neurons (Fig 5A,B). This proliferating activity, most likely corresponding to the 396 
neurogenesis peak of those progenitors that will populate later the upper cortical layers, 397 
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vastly ceased as the cells progressed to DIV4, which was accompanied by a moderate 398 
increase in the apoptotic index to similar levels in all three genotypes analyzed (Fig 5A,C). 399 
Accordingly, coronal brain sections from E15,5 embryos stained with the newly born 400 
neurons marker Doublecortin revealed a clear reduction of the neuronal progenitor cells in 401 
the PDK1fl/fl CRE- and PDK1fl/fl CRE+ embryos compared to the PDK1+/fl CRE- controls 402 
(Fig 5D,E). By contrast, no evidence of apoptosis was observed in any of the three 403 
genotypes analyzed, as judged by the nearly absence of active caspase-3 staining (Fig 5D,F). 404 
Since soma size analysis of hippocampal neurons in culture revealed a genotype dependent 405 
decrease in the diameter of the cellular soma (Fig. 6D), altogether our data demonstrates a 406 
combined reduction in progenitor proliferation and cell growth responses.  407 
PDK1 promotes neuronal polarization and axonal outgrowth through the PIF-pocket 408 
dependent substrates. 409 
The PI 3-kinase signaling pathway controls several aspects of neuronal morphogenesis 410 
including neuronal polarization, axonal outgrowth and dendrite arborization (38). In the 411 
PDK1K465E/K465E mice, the Akt/mTORC1 axis was instructive for PI 3-kinase mediated 412 
neuronal polarization and axon outgrowth (22). Since S6K is a major effector of mTORC1 413 
in controlling the translation of proteins that are relevant for neuronal differentiation, we 414 
reasoned that the PDK1 L155E mice model, with normal levels of Akt activity but in which 415 
S6K cannot be activated by PDK1, could be instrumental in defining the contribution of 416 
S6K to neuronal differentiation. To that end, we analyzed cell polarization and measured 417 
the axon length during the differentiation of hippocampal primary neurons in culture. In the 418 
PDK1+/fl CRE- control cultures, most of the neurons exhibited a differentiated axon by 419 
DIV3, as denoted by the expression of the axonal specific microtubule-associated protein 420 
Tau-1. By contrast, neuronal polarization was severely impaired in both the PDK1fl/fl CRE- 421 
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and PDK1fl/fl CRE+ mutant hippocampal cultures, in which only half of the neurons showed 422 
axons by DIV3 and 4 (Fig 6A,B). The complexity of the neuritic processes, as inferred 423 
from the number of neurites per cell (Fig 6C), as well as their length and the amount of 424 
ramifications (Fig 6E), was similar in PDK1+/fl CRE-, PDK1fl/fl CRE- and PDK1fl/fl CRE+ 425 
mice hippocampal neurons at all the time points analyzed. By contrast, the average length 426 
of the axon was reduced by thirty per cent in the PDK1fl/fl CRE- neurons and as much as 427 
forty per cent in the PDK1fl/fl CRE+ neurons when compared to the PDK1+/fl CRE- control 428 
cells, both at DIV3 and 4 (Fig 6E). 429 
Reduced connectivity and abnormal cortical layering in the mutant mice adult brain. 430 
We next explored how the deficient differentiation abilities of the PDK1fl/fl CRE- and 431 
PDK1fl/fl CRE+ embryonic neurons detected ex vivo had physiological consequences in the 432 
adult brain. Immunostaining of brain sections with antibodies to microtubule-associated 433 
proteins that are selectively localized in either axons (SMI312) or dendrites (MAP2) 434 
revealed a clear decrease in the density of axonal fibers in various regions of the PDK1fl/fl 435 
CRE- and PDK1fl/fl CRE+ cortex (Fig 7A) and hippocampus (Fig 7B), in a genotype dose-436 
dependent manner. 437 
The PI 3-kinase signaling pathway also controls the radial migration of new-born cortical 438 
neurons during cortex development, resulting in an ordered arrangement of neurons into six 439 
different cortical layers. It has been proposed that Akt, but not mTORC1, controls cortical 440 
development downstream of PI 3-kinase activation (39). Since the neuronal differentiation 441 
program is integrated with the program of neuronal migration, we aimed to determine 442 
whether the PI 3-kinase/PDK1 effectors that are independent of Akt activation were also 443 
important for cortical development. We observed that in the PDK1fl/fl CRE- adult brain, 444 
neurons in layer IV of the somatosensory cortex were packed together (Fig 8B) and further 445 
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compacted in the PDK1fl/fl CRE+ mice (Fig 8C) when compared to the PDK1+/fl CRE- 446 
controls (Fig 8A), as revealed by immunohistochemical analysis with the NeuN neuronal 447 
marker. 448 
Cortical layer IV is mainly composed of pyramidal neurons and gabaergic interneurons. For 449 
that reason, we employed antibodies against CUX1, a transcription factor which is 450 
expressed in glutamatergic cortical neurons from upper layers II to IV of the somatosensory 451 
cortex, and GAD67, the decarboxylase which catalyze the conversion of glutamate to the 452 
GABA inhibitory neurotransmitter in the gabaergic interneurons. While CUX1 staining 453 
confirmed that the neuronal packing arises from an increase in the glutamatergic neurons 454 
cell density with normal number of cells (Fig 9A-D), a clear decrease in the GAD67 455 
expression in the somatosensory cortex (Fig 9A,E) and cingulated cortex (Fig 9F) was 456 
observed, arising from the increase in the PDK1 L155E mutant protein levels across the 457 
different genotypes analyzed. Moreover, the parvalbumin-positive interneurons were 458 
mostly excluded from layer IV in the PDK1fl/fl CRE+ cortex samples when compared with 459 
its distribution in the PDK1fl/fl CRE- and PDK1+/fl CRE- cortex (Fig 9B). 460 
Neuropsychiatric-like behaviors in the brain-specific PDK1 L155E mutant mice. 461 
A three-stage protocol for behavioral and functional comprehensive phenotype assessment 462 
of mutant mice (28,29) evaluated the physical condition, sensorimotor functions, behavioral 463 
and psychological profiles (spontaneous behavior, locomotor and exploratory activities, 464 
anxious-like behaviors, motivation) as well as cognition (learning and memory, attention, 465 
executive functions). Somatic growth, as measured by body weight, was reduced with 466 
lower food intake (Fig 10A). Sensorimotor functions were severely reduced by two-fold, 467 
even in an easy task as the wood rod test (Fig 10B). A deficiency in a highly preserved 468 
daily life ethological activity such as nesting behavior evidenced impairment of executive 469 
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functions (Fig 10C). The mutant mice showed apparent undisturbed behavior in the 470 
homecage, with normal socialization and sleeping in groups but absence of barbering. 471 
Disrupted behavior aroused when handled, with high incidence of hyper-reactivity shown 472 
as rejection to be handled (5/6), vocalizations (3/6), bizarre behaviors (4/6) (Fig 10D, 473 
stereotyped stretching), refusal to perform the tests such as the hanger test (6/6) and 474 
diminished motivation to swim in the water maze (Fig 10G, flotation). Neophobia in the 475 
corner test suggested a flight-behavior, which in a more anxiogenic environment such as 476 
the open-field test (Fig 10E), turned into freezing behavior. An overall reduced total 477 
vertical exploratory activity was observed, while the thigmotaxis ratio (locomotion in the 478 
periphery vs center) was maintained in the mutants. These results were confirmed in the 479 
84h continuous circadian activity recordings in a cage equipped with a wheel (Fig 10H). In 480 
that setting, the time course from the first (novelty) to the fourth (habituation) night was 481 
strikingly reduced in the mutant mice, mostly within the first two nocturnal activity periods. 482 
In the marble burying test, the mutants exhibited a higher number of marbles changed of 483 
position, in detriment of the number of buried pieces (Fig 10F). With respect to their 484 
cognitive abilities, both groups solved equally the first experience in the water maze. 485 
However, a poorest acquisition curve was seen in the mutant group, resulting in a worse 486 
cognitive capacity at the end of the perceptual visual learning paradigm which involves 487 
attention and motivation (Fig 10G, CUE1-4). Similarly, on the following days, mutant mice 488 
showed cognitive deficits in their spatial learning and memory abilities in the place learning 489 
task. They performed similarly in the first trial of each day (long-term memory) but did not 490 
progress successfully in the trial-by-trial test (short-term and working memory), again with 491 
a worse learning curve and ratios, as compared to their age matched wild-type group. A 492 
higher incidence of periods of immobility (flotation), as a non-searching behavior 493 
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indicative of changes in motivation in the mutants, was also shown all through the test (Fig 494 
10G).495 
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Discussion 496 
In the present study we characterized the Akt-independent roles that the PDK1 signaling 497 
pathway plays during brain development. Disrupting the interaction of PDK1 with its 498 
substrates in the PDK1L155E/L155E full knock-in mice resulted in an embryonic lethal 499 
phenotype, with embryos dying at E12 exhibiting severe retardation and a major reduction 500 
in the forebrain size, thereby highlighting the essential roles that the Akt independent 501 
branch of the PDK1 signaling network played during embryonic development (23,40). To 502 
circumvent this lethal period, we targeted the expression of the PDK1 L155E mutant 503 
protein to neuronal tissues by conditional knock-in methodologies. The PDK1fl/fl CRE+ 504 
genotype was observed at birth at a three-fold reduced mendelian frequency. By contrast, 505 
the PDK1fl/fl CRE- controls were born at the expected frequency, thus indicating that low 506 
levels of PDK1 wild type protein were sufficient for the PDK1fl/fl CRE- mice to complete 507 
embryonic development, and that the further and specific ablation of the wild type PDK1 508 
sequence in the nervous system was responsible for the lethality of the PDK1fl/fl CRE+ 509 
mutant embryos. The hypomorphic nature of the PDK1 L155E conditional knock-in allele, 510 
which can drive the expression of as much as sixty-seventy per cent of PDK1 L155E 511 
mutant protein without compromising the viability of these mice, makes the PDK1fl/fl 512 
conditional knock-in mice an excellent genetic tool to study the function of PDK1 beyond 513 
Akt in a more physiological context. At the same time, these mice could represent the 514 
appropriate experimental model to validate the effects of new allosteric modulators 515 
targeting the PDK1 PIF-pocket, which are nowadays being developed and hold an 516 
enormous therapeutic potential (41). 517 
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Activation of S6K, RSK, SGK and PKC, but not Akt, was selectively decreased in the 518 
PDK1fl/fl CRE- mouse cortical neurons, when compared to the PDK1+/fl CRE- controls, and 519 
further abolished in the PDK1fl/fl CRE+ neuronal cells and tissues. We and others recently 520 
described how in the absence of PtdIns(3,4,5)P3 binding, PDK1 can still activate Akt by 521 
binding to the phosphorylated Akt hydrophobic motif (42,43). In agreement with that, in 522 
the PDK1K465E/K465E knock-in mice expressing a mutant form of PDK1 incapable of 523 
phosphoinositide binding, activation of Akt was selectively affected, but not fully abolished 524 
(22). By contrast, in the PDK1fl/fl CRE+ neurons and tissues, Akt was normally activated, 525 
thereby demonstrating that in physiological conditions, Akt activation by PDK1 rely mostly 526 
on the phosphoinositide-mediated co-localization of both kinases at PtdIns(3,4,5)P3-rich 527 
cellular membranes rather than on the docking site interaction. 528 
The reduced phosphorylation of S6K and RSK at their activation loops by PDK1 arises 529 
from the inability of the PDK1 L155E mutated PIF-pocket to interact with the phospho-530 
hydrophobic motif docking site in S6K and RSK. Unexpectedly, the level of 531 
phosphorylation of S6K at the Thr389 and RSK at the Ser380 hydrophobic motif sites was 532 
also decreased to the same extent than that of the activation loops. The AGC kinases 533 
possess and hydrophobic groove in the small lobe of their kinase domains similar to the 534 
PDK1 PIF-pocket. This hydrophobic pocket establishes intramolecular interactions with the 535 
phosphorylated hydrophobic motif that are fundamental for the transition of the enzyme to 536 
the active conformation (44). In the absence of activation loop phosphorylation, the active, 537 
closed conformation is not favored, which may allow the exposure of the hydrophobic 538 
motif phosphorylation site to the action of phosphatases (23). 539 
PDK1 plays a major role in the processing and maturation of several PKC isoforms. Newly 540 
synthesized PKC polypeptides are first phosphorylated at their hydrophobic motifs 541 
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allowing PDK1 to interact and phosphorylate the T-loops. These first phosphorylation 542 
events do not depend on apical agonist-stimulation, and stabilize the enzyme in a 543 
catalytically inactive conformation but at the same time competent to respond to the 544 
diacylglycerol and calcium second messengers (45,46). In agreement with that notion, both 545 
the levels of phosphorylation as well as the levels of expression of PKCα were reduced in 546 
the PDK1fl/fl CRE+ embryonic brain samples as well as cortical cell extracts, but not in the  547 
PDK1fl/fl CRE- samples when compared to the PDK1+/fl CRE- controls (Fig. 3), thereby 548 
indicating that the reduced levels of expression of the wild type PDK1 protein in the 549 
PDK1fl/fl CRE- mice were sufficient to regulate phosphorylation and stability of PKC 550 
isoforms, which was unchanged upon BDNF stimulation of cortical neurons (Fig 3A). 551 
One salient finding derived from these studies is that disrupting the interaction of PDK1 552 
with their substrates in the PDK1fl/fl CRE+ mutant mice has not consequences regarding 553 
neuronal survival. This is consistent with the fact that the PKB/Akt kinase, which is the 554 
only PDK1 substrate that is not affected by the PDK1 L155E mutation, is thought to be the 555 
critical downstream effector of this pathway in promoting survival by antagonizing the 556 
programmed cell death (47). However, in the PDK1K465E/K465E knock-in mice, reduced 557 
activation of Akt isoforms was also sufficient to dictate neuronal survival (22). We recently 558 
demonstrated how the inhibition of mTORC2, the Akt and SGK hydrophobic motif kinase, 559 
modestly compromised the viability of the PDK1 wild type neurons at doses that did not 560 
affect Akt activation, and that was further aggravated in the PDK1K465E/K465E mutant 561 
neurons (43). Altogether, these results point out to a synergistic role of both Akt and SGK 562 
in controlling neuronal survival by coordinately regulating the phosphorylation of some 563 
substrates that are relevant to the control of apoptosis. By contrast, both cell proliferation 564 
and cell growth were reduced in the PDK1fl/fl CRE+ mutant mice, which might arise from 565 
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the inability of PDK1 to activate S6K despite unaffected PI3K/Akt/mTORC1 signaling. 566 
These results situate S6K as the most critical downstream effector of this signaling pathway 567 
in instructing cell and organism growth. 568 
The observation that both the neuronal polarization and axonal elongation responses of 569 
hippocampal neurons from the PDK1fl/fl CRE- and PDK1fl/fl CRE+ mice were inhibited by 570 
the PDK1 PIF-pocket mutation is particularly relevant, since the establishment of the axon-571 
dendrite axis is an essential morphogenetic mechanism for the appropriate assembly of 572 
neurons onto functional neuronal circuits. This process is triggered by different 573 
extracellular signals acting through a number of intracellular signaling pathways. Among 574 
them, the interplay between the PI3K/Akt signaling pathway (48), the Par3-Par6-aPKC 575 
complexes (4) and the LKB1/BRSK axis (49,50) is fundamental in controlling axon 576 
specification and growth. In agreement with that, in the PDK1K465E/K465E mice, the 577 
PI3K/Akt/mTORC1-dependent regulation of the BRSK protein levels represents an 578 
integration point for both the PI3K and LKB1 signaling pathways in axonal morphogenesis 579 
(22). In these mice, the hypomorphic reduction of the Akt signaling towards the 580 
PRAS40/TSC2/mTORC1/S6K axis caused mild phenotypes that could be mimicked ex 581 
vivo with the Akti-1/2 inhibitory compound, which reduced Akt activity by inhibiting the 582 
Akt1 and Akt2, but not the Akt3 isoform, and aggravated by using the mTORC1 inhibitor 583 
rapamycin. Interestingly, in the PDK1fl/fl CRE- and PDK1fl/fl CRE+ mice, in which the 584 
PI3K/Akt/mTORC1 axis is normally activated, the defects in both the polarity and the 585 
axonal elongation processes were more severe that those reported in the PDK1K465E/K465E 586 
mice, which phenocopied the severe differentiation defects previously observed with the 587 
mTORC1 inhibitor (22). Altogether, these observations place a PIF-pocket dependent 588 
kinase, namely S6K, as a key effector of the PI3K/Akt/mTORC1 axis in controlling the 589 
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synthesis of proteins that are relevant for neuronal morphogenesis. Moreover, while in the 590 
PDK1K465E/K465E mice the transient alterations in the timing of the differentiation program 591 
did not translate onto gross abnormalities in the patterning of the adult brain (22), the 592 
genetic ablation of S6K activation with intact Akt signaling in the PDK1fl/fl CRE+ adult 593 
mice caused microcephaly with profound structural and molecular brain alterations, thereby 594 
ruling out the implication of other Akt or mTORC1 substrates different from S6K on these 595 
phenotypes. 596 
Further experiments must be undertaken in the future to elucidate the connection between 597 
the impaired PDK1 PIF-pocket-dependent signaling in mutant mice and the altered 598 
population of interneurons denoted by the GAD67 and parvoalbumin markers defects. In 599 
this regard, defects in the translation machinery in neurons caused by elongator subunit 600 
Elp3 deletion have been recently related to impaired neuronal differentiation and 601 
imbalanced neurogenesis, leading to microcephaly resulting from the premature migration 602 
of neurons (51,52). In an analog form, the S6K PIF-pocket dependent kinase is 603 
indispensable for the pre-initiation complex (PIC) formation and protein translation (53,54). 604 
Abrogation of S6K activation in the PDK1 L155E mutant mice could have impaired the 605 
normal protein translation in neurons leading to imbalanced neurogenesis, thereby 606 
generating a potential molecular connection between the PIF-pocket mutation and the 607 
described brain defects associated to microcephaly. Moreover, the deficient polarization 608 
and axonal outgrowth of the PDK1 L155E mutant neurons might have caused altered 609 
migration patterns during cortex lamination, contributing to the decreased density of axonal 610 
fibers in the cortex and hippocampus, increased density of glutamatergic neurons with 611 
normal number of cells in cortical layers II-IV, decreased GAD67 expression levels, and 612 
miss-localized parvalbumin-positive interneurons, which were mostly excluded from layer 613 
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IV. Intriguingly, these alterations are commonly observed in human mental diseases such as 614 
schizophrenia. These included reduced axonal density in the cortex and the hippocampus 615 
(55), elevated neuronal density in cortical layer IV (56), GAD67 deficits in the upper 616 
cortical layers, especially in the cingulated cortex (57), and abnormal localization of the 617 
parvalbumin positive interneurons (58). The current hypotheses on the etiology of 618 
schizophrenia state that this molecular and structural scenario is thought to result in 619 
deregulated GABAergic interneuron-mediated inhibition of glutamatergic neurons, 620 
resulting in an over-activation of the neuronal circuits and contributing in this manner to the 621 
characteristic symptoms of this disease. 622 
In the PDK1fl/fl CRE+ mice, the behavioral disturbances included a wide array of 623 
impairments, ranging from sensorimotor and basic species executive functions, to both 624 
cognitive and non-cognitive behavioral alterations. The different tests assessed convey to 625 
point out to relevant and persistent bizarre behaviors, severe reduction of exploratory 626 
activity, increased freezing, diminished motivation and impaired short-term working 627 
memory. Much future work need to be performed to define whether the presence of both 628 
exacerbated disruptive behavior suggesting an hypersensitivity to stressful situations, but 629 
reduced activity and diminished motivation would have face validity for negative 630 
symptoms that characterize the clinical features of the schizophrenia spectrum (59). 631 
Moreover, cognitive impairment with affection of learning and memory but also attention 632 
and executive functions, would be also compatible with cognitive clinical symptoms of 633 
schizophrenia. 634 
Human schizophrenia might arise from an inherited genetic predisposition causing brain 635 
developmental alterations combined with environmental factors that can influence brain 636 
maturation during the childhood. A number of genes that have been associated to familiar 637 
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forms of schizophrenia converge onto the same signaling pathway. These include the 638 
neuregulin-1 (NRG1) growth factor coding-gene (60,61), the dystrobrevin-binding protein 639 
1 (DTNBP1) gene (12) the DISC1 scaffolding protein coding gene (13), as well as the Akt1 640 
gene (11), which altogether participate in the modulation of the Akt signaling outputs. To 641 
our knowledge, this is the first report evidencing the involvement of PDK1 downstream 642 
effectors different from Akt in mice neuropsychiatric-like disorders, with potential face and 643 
construct validity for negative and cognitive symptoms of schizophrenia. Our results point 644 
out to a prominent function for PIF-pocket dependent kinases as major effectors of this 645 
signaling hub downstream of Akt in the etiopathogenesis of schizophrenia that might 646 
provide construct validity to the PDK1 L155E mutants. 647 
648 
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Figure Legends. 855 
FIG 1. Generation of brain-specific PDK1 L155E mice. (A) Diagram depicting the 5’-end 856 
of the PDK1 gene from exons 2 to 7 (PDK1); the targeting construct containing the 857 
thymidine kinase (TK) negative selectable marker and the minigene cassette, which 858 
includes the PDK1 open reading frame from exons 3 to 14 plus the natural polyadenylation 859 
signals (A+), and is flanked by LoxP sites (CONSTRUCT); the targeted allele, which drives 860 
the expression of the PDK1 wild type protein in control tissues (PDK1 WT), and the 861 
excised allele in which the CRE-Recombinase mediated deletion of the minigene cassette 862 
allows the expression of the PDK1 mutant protein (PDK1 L155E). The white boxes 863 
represent exons, the black triangles represent LoxP sites, and the mutated exon four 864 
containing the Leu155Glu amino acid substitution is black–filled and labeled with an 865 
asterisk. (B) Breeding strategy used for the generation of mice expressing the PDK1 L155E 866 
mutant protein in brain. The number (n) and proportion (%) of mice of each genotype 867 
resulting from the depicted experimental breeding are indicated both at embryonic day 15.5 868 
(E15) and at birth (P0). ** indicates that the lower-than-expected frequency of PDK1fl/fl 869 
CRE+ pups is statistically significant (P < 0.005 by χ2 test). (C) PDK1 was affinity purified 870 
on PIF-sepharose from liver or brain embryonic extracts of the indicated genotypes. The 871 
expression levels of the PDK1 wild type protein were quantified on the indicated genotypes 872 
and tissues from the PDK1 immunoblot signals of the PIF-Sepharose pulldowns (middle 873 
panels), normalized by the total PDK1 protein levels derived from the whole tissue lysate 874 
immunoblot signals (upper panels), and represented as percentage of the PDK1+/fl CRE-  875 
controls. Each bar represents the means ± standard errors of the mean for the immunoblot 876 
signals derived from two independent experiments. A representative western blot is shown, 877 
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where each lane corresponds to a sample derived from a different mice. Immunoblots with 878 
the ERK1/2 antibody are also shown as control of protein loading (bottom panels). 879 
 880 
FIG 2. Microcephaly of the PDK1fl/fl CRE+ mice.  The organ volume was measured from 881 
physical histological sections of the E15,5 embryo head (A) and brain (C) or MRI-obtained 882 
images of one hemisphere of the adult brain (D) by using the Cavalieri method as described 883 
in Materials and Methods. The data are represented as the means ± standard errors of the 884 
mean obtained for three different mice per genotype, and are expressed as percentage of the 885 
controls. The total volume values and representative photographs of the E15,5 embryonic 886 
brains or adult brain left hemispheres are shown at the bottom, where the scale bars 887 
correspond to 1 mm and 2 mm, respectively. (B) The mean body weights of mice of the 888 
indicated genotypes are shown. The values represent the means ± standard errors of the 889 
mean for the indicated number of mice (n). (E and F) The number of cells (E) and the 890 
cellular volume (F) were determined from E15.5 dissociated cortical neurons with a 891 
ScepterTM 2.0 Handheld Automated Cell Counter (Millipore). The data are represented as 892 
the means ± standard errors of the means for the indicated number of embryos (n) obtained 893 
from 11 independent litters. 894 
 895 
FIG 3. Activation of S6K1, RSK, SGK1 and PKC, but not Akt, is inhibited in the PDK1fl/fl 896 
CRE + mice. (A) Cortical neurons from three independent embryos of the indicated 897 
genotypes were cultured for 6 DIV, then serum starved for 4 h and either left unstimulated 898 
or stimulated with 50 ng/ml of BDNF for 15 minutes. (B) Whole brain protein extracts 899 
were obtained at E15,5 from three independent embryos of each depicted genotype. Lysates 900 
were immunoblotted with the indicated antibodies to monitor the activation of Akt, S6K, 901 
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RSK, SGK and PKC, were each lane corresponds to a different embryo. Band densitometry 902 
quantification of the ratio between phosphorylated and total protein levels is shown at the 903 
bottom, where bars represent the means ± standard errors of the mean obtained for the three 904 
different mice per genotype analyzed, and are expressed as percentage of the BDNF-905 
stimulated control samples (A) or control brain tissue samples (B). 906 
 907 
FIG 4. Neuronal survival responses are preserved in the PDK1fl/fl CRE+ mice. Cortical cells 908 
of the indicated genotypes were either sham treated (CONTROL) or deprived of trophic 909 
factors in the absence (TD) or presence of 50 ng/ml of BDNF (TD+BDNF) for 24 h. Data 910 
represent the means ± standard errors of the means for at least 3 independent mouse 911 
embryos per genotype from 6 independent litters. (A) Viability was determined with the 912 
MTT reduction assay and is expressed as a percentage of the untreated cells. (B) The 913 
percentage of apoptotic cells was obtained by scoring the number of nuclei exhibiting 914 
chromatin fragmentation from six different fields per well and 4 wells per condition divided 915 
by the total. (C) Representative micrographs of Hoechst-stained cortical neurons of the 916 
indicated genotypes after 24 h of the indicated treatment; arrowheads indicate apoptotic 917 
nuclei. Bar, 20 μm. 918 
 919 
FIG 5. Reduced neuronal progenitor proliferation in the PDK1fl/fl CRE- and PDK1fl/fl CRE+ 920 
embryos. (A) Representative micrographs of E15,5 embryonic cortical cultures of the 921 
indicated genotypes immunostained with the described antibodies. Bar, 40 μm. The 922 
percentage of primary cortical neurons expressing the Ki67 proliferation marker (B) or the 923 
active caspase-3 apoptotic marker (C) were scored at the indicated time points, were each 924 
bar corresponds to the means ± standard errors of the means from ten different fields per 925 
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culture and three independent embryonic cultures per genotype. (D) Epifluorescence 926 
microscopy images of E15,5 embryonic brain coronal sections of the indicated genotypes 927 
immunostained with the described antibodies. Bar, 100 μm. The intensity of Doublecortin 928 
(DCX) staining (E) and the number of caspase-3 positive cells per field (F), were quantified 929 
and expressed as the mean ± standard error of the mean from three independent sections per 930 
embryo obtained from three different embryos per genotype. 931 
 932 
FIG 6. Deficient polarization and axonal outgrowth in the PDK1fl/fl CRE- and PDK1fl/fl 933 
CRE+ mice. (A) Representative micrographs of hippocampal cultures from the indicated 934 
genotypes at different days in vitro (DIV) stained with the dendrite-specific marker MAP2 935 
(red) and the specific axonal marker Tau-1 (green). Bar, 50 μm. (B and D) The percentage 936 
of polarization (B), the number of neurites per cell (C), the diameter of the soma (D) and 937 
the length of neurites, neurites ramifications and axons (E), were measured at different time 938 
points on samples from the indicated genotypes. Each bar represents the mean ± standard 939 
error of the mean for 100 neurons from three different embryos per condition. 940 
 941 
FIG 7. Reduced connectivity in the PDK1fl/fl CRE- and PDK1fl/fl CRE+ mice brain. (A) 942 
Epifluorescence micrographs of coronal sections of the somatosensory cortex from mice 943 
brains of the indicated genotypes stained with the dendrite-specific marker MAP2, the 944 
general axonal marker SMI312, and the nuclear Hoechst dye. The merged signals are also 945 
shown. Cortical layers are depicted on the right from I to VI. Bar, 100 μm. 946 
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(B) Image magnifications of cortical layers IV and VI, as well as the hippocampal dentate 947 
girus (DG), CA3 and CA1 regions stained with SMI312 and Hoechst. Arrowheads indicate 948 
differences in the density of axonal fibers between genotypes. Bar, 50 μm. 949 
FIG 8. Abnormal cortical layering with compactation of Layer IV in PDK1fl/fl CRE- and 950 
PDK1fl/fl CRE+ mice brain. (A and C) Epifluorescence microscopy images of coronal 951 
sections of the somatosensory cortex from mice of the indicated genotypes stained with the 952 
neuronal marker NeuN and the nuclear Hoechst dye, as indicated. Adjacent hematoxylin-953 
and-eosin (H-E)-stained sections and the merged signals are also shown. Bar, 100 μm. 954 
Cortical layers are indicated on the right from I to VI. A low magnification micrograph of 955 
the hematoxylin-and-eosin (H-E)-stained sections and a high magnification of the merged 956 
epifuorescence images corresponding to layers II to V are also shown at the top of each 957 
panel. 958 
 959 
FIG 9. Reduced GAD67 levels and abnormal parvalbumin-staining patterns in the PDK1fl/fl 960 
CRE- and PDK1fl/fl CRE+ mice brain. (A and B) Epifluorescence microscopy images of 961 
coronal sections of the somatosensory cortex from mice of the indicated genotypes stained 962 
with the layer II to IV-specific marker CUX1, the gabaergic neuron-specific marker 963 
GAD67, the interneuron marker parbalvumin, and the nuclear Hoechst dye, as indicated. 964 
Cortical layers are indicated on the right from I to VI. Bar, 100 μm. (C and E) The density 965 
of neurons in layer IV (C), the percentage of CUX1-positive neurons in layer IV among the 966 
total number of CUX1-positive neurons in layers I to IV (D), and the intensity of GAD67 967 
staining (E), were quantified and expressed as the mean ± standard error of the mean from 968 
three independent sections per embryo obtained from three different embryos per genotype. 969 
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(F) Epifluorescence microscopy images of coronal sections of the cingulated cortex from 970 
mice of the indicated genotypes stained with the the gabaergic neuron-specific marker 971 
GAD67 and the nuclear Hoechst dye. Higher magnification images of layer II-III (a) and 972 
layer V (b) regions are also shown. Bar, 200 μm. 973 
 974 
FIG 10. Disruptive behavior with diminished motivation and cognitive deficits in the 975 
PDK1fl/fl CRE+ mice. (A and H) The somatic growth–related parameters (A), the 976 
sensorimotor performance on the wood rod test (B), the executive functions in the nesting 977 
behavior daily life activity (C), the incidence of bizarre behaviors (D), the exploratory 978 
activity and anxiety-like behaviors in a standard open-field test (E), the level of interaction 979 
in the marble-burying test (F), the cognitive abilities in the water maze and depression-like 980 
diminished motivation measured by episodes of immobility (G) and the circadian activity 981 
on running wheels (H) were assessed on six PDK1fl/fl CRE- (WT, black bars and dots) and 982 
six PDK1fl/fl CRE+ (L155E, white bars and dots) adult female mice. 983 










